This brand name is authorized in Estonia, Israel, Lithuania, Malta
The drug IMOVAX DT ADULT contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Purified diphtheria toxoid, inactivated, adsorbed
UNII IRH51QN26H - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
|
|
2
Purified tetanus toxoid, inactivated, adsorbed
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AM51 | Tetanus toxoid, combinations with diphtheria toxoid | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AM Tetanus vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1101272 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 7531 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1009860, 1015239 |
| Country: MT | Medicines Authority | Identifier(s): MA573/01001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
